Those determined to outshine the market strategically focus on the selection of individual stocks. Well-chosen stocks have the potential to substantially boost your wealth.
The closing price of Caredx Inc (NASDAQ: CDNA) was $12.6 for the day, up 3.11% from the previous closing price of $12.22. In other words, the price has increased by $3.11 from its previous closing price. On the day, 1.26 million shares were traded. CDNA stock price reached its highest trading level at $12.88 during the session, while it also had its lowest trading level at $12.09.
Ratios:
Our analysis of CDNA’s different ratios will help us gain a deeper understanding of the company. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 3.04 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 34.82. For the most recent quarter (mrq), Quick Ratio is recorded 3.84 and its Current Ratio is at 4.11. In the meantime, Its Debt-to-Equity ratio is 0.08 whereas as Long-Term Debt/Eq ratio is at 0.06.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Wells Fargo on January 15, 2025, Upgraded its rating to Equal Weight and sets its target price to $24 from $28 previously.
On August 28, 2024, Wells Fargo started tracking the stock assigning a Underweight rating and target price of $28.
BTIG Research Upgraded its Neutral to Buy on August 19, 2024, while the target price for the stock was maintained at $40.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Jul 07 ’25 when Maag Peter sold 10,000 shares for $18.58 per share. The transaction valued at 185,831 led to the insider holds 308,846 shares of the business.
Valantine Hannah sold 10,570 shares of CDNA for $202,566 on Jun 18 ’25. The Director now owns 38,994 shares after completing the transaction at $19.16 per share. On Jun 17 ’25, another insider, Maag Peter, who serves as the Director of the company, sold 10,000 shares for $19.24 each. As a result, the insider received 192,420 and left with 318,846 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CDNA now has a Market Capitalization of 701574336 and an Enterprise Value of 500934912. As of this moment, Caredx’s Price-to-Earnings (P/E) ratio for their current fiscal year is 10.94, and their Forward P/E ratio for the next fiscal year is 198.96. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.03 while its Price-to-Book (P/B) ratio in mrq is 1.84. Its current Enterprise Value per Revenue stands at 1.446 whereas that against EBITDA is -19.857.
Stock Price History:
The Beta on a monthly basis for CDNA is 2.26, which has changed by -0.49620152 over the last 52 weeks, in comparison to a change of 0.20799685 over the same period for the S&P500. Over the past 52 weeks, CDNA has reached a high of $34.84, while it has fallen to a 52-week low of $10.96. The 50-Day Moving Average of the stock is -26.91%, while the 200-Day Moving Average is calculated to be -37.32%.
Shares Statistics:
CDNA traded an average of 1.52M shares per day over the past three months and 1207920 shares per day over the past ten days. A total of 55.46M shares are outstanding, with a floating share count of 51.93M. Insiders hold about 6.73% of the company’s shares, while institutions hold 102.80% stake in the company. Shares short for CDNA as of 1752537600 were 6399574 with a Short Ratio of 4.21, compared to 1749772800 on 6276371. Therefore, it implies a Short% of Shares Outstanding of 6399574 and a Short% of Float of 11.75.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
Earnings Estimates
At present, 5.0 analysts are actively evaluating the performance of Caredx Inc (CDNA) in the stock market.The consensus estimate for the next quarter is $0.15, with high estimates of $0.18 and low estimates of $0.11.
Analysts are recommending an EPS of between $0.64 and $0.47 for the fiscal current year, implying an average EPS of $0.57. EPS for the following year is $0.95, with 5.0 analysts recommending between $1.13 and $0.74.
Revenue Estimates
It is expected that $90B in revenue will be generated in the current quarter, according to 7 analysts. It ranges from a high estimate of $91.78M to a low estimate of $89.5M. As of the current estimate, Caredx Inc’s year-ago sales were $92.27MFor the next quarter, 7 analysts are estimating revenue of $94.07M. There is a high estimate of $95.63M for the next quarter, whereas the lowest estimate is $90M.
A total of 7 analysts have provided revenue estimates for CDNA’s current fiscal year. The highest revenue estimate was $374M, while the lowest revenue estimate was $358.7M, resulting in an average revenue estimate of $369.13M. In the same quarter a year ago, actual revenue was $333.79MBased on 7 analysts’ estimates, the company’s revenue will be $417.39M in the next fiscal year. The high estimate is $429M and the low estimate is $394.3M.
